Rockefeller Capital Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Rockefeller Capital Management’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,265	Closed	-$225K	–	4026
2022 Q4	$225K	Buy	4,265 +246	+6%	+$12K	﹤0.01%	1606
2022 Q3	$180K	Buy	4,019 +3,980	+10,205%	+$171K	﹤0.01%	1699
2022 Q2	$1K	Hold	39	–	–	﹤0.01%	4047
2022 Q1	$1K	Buy	39 +14	+56%	+$493	﹤0.01%	3805
2021 Q4	$1K	Sell	25 -12	-32%	-$600	﹤0.01%	3710
2021 Q3	$2K	Buy	37 +12	+48%	+$628	﹤0.01%	3500
2021 Q2	$1K	Buy	25 +14	+127%	+$713	﹤0.01%	3394
2021 Q1	$0	Sell	11 -63	-85%	-$3.5K	﹤0.01%	3421
2020 Q4	$4K	Buy	74 +25	+51%	+$1.55K	﹤0.01%	2523
2020 Q3	$3K	Buy	49 +18	+58%	+$982	﹤0.01%	2376
2020 Q2	$1K	Buy	+31	New	+$1.19K	﹤0.01%	2531

Other funds holding SILK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Rockefeller Capital Management's SILK Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q1 2023, closing a stake of 4,265 shares — an estimated $225K sold.

Rockefeller Capital Management first reported a position in SILK in Q2 2020 and held it in 11 quarters. The position peaked at $225K in Q4 2022. 194 funds tracked by Wall St. Rank hold SILK as of Q1 2023.

Rockefeller Capital Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Rockefeller Capital Management sold 4,265 Silk Road Medical, Inc. Common Stock shares in Q1 2023, an estimated $225K.
Rockefeller Capital Management first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2020 and held it in 11 quarters.
Rockefeller Capital Management's Silk Road Medical, Inc. Common Stock position peaked at $225K in Q4 2022.
194 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.